Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hatsumi Sugiyama"'
Autor:
Manami Suzuki, Kentarou Takei, Hisatoshi Sugiura, Kei Sato, Tsutomu Tamada, Koji Murakami, Hirohito Sano, Naoki Tode, Yoko Tsukita, Daisuke Narita, Nozomu Kimura, Shuichiro Matsumoto, Yoshinao Ono, Chikashi Iwasaki, Hatsumi Sugiyama, Sho Kakuto, Shuichi Konno, Hajime Kanamori, Hiroaki Baba, Kengo Oshima, Koichi Tokuda
Publikováno v:
BMJ Open Respiratory Research, Vol 9, Iss 1 (2022)
Rational Corticosteroid therapy plays a key role in the treatment of COVID-19 patients with respiratory failure. However, a rebound phenomenon after steroid cessation rarely occurs. Here, we investigated the clinical features of patients with rebound
Externí odkaz:
https://doaj.org/article/6088d4c0a91548638130220f7dc5d3ac
Autor:
Koji Murakami, Hirohito Sano, Naoki Tode, Yoko Tsukita, Kei Sato, Daisuke Narita, Nozomu Kimura, Shuichiro Matsumoto, Yoshinao Ono, Chikashi Iwasaki, Hatsumi Sugiyama, Manami Suzuki, Sho Kakuto, Shuichi Konno, Hajime Kanamori, Hiroaki Baba, Kengo Oshima, Kentarou Takei, Koichi Tokuda, Tsutomu Tamada, Hisatoshi Sugiura
Publikováno v:
BMJ Open Respiratory Research. 9:e001332
RationalCorticosteroid therapy plays a key role in the treatment of COVID-19 patients with respiratory failure. However, a rebound phenomenon after steroid cessation rarely occurs. Here, we investigated the clinical features of patients with rebound
Autor:
Toshikazu Sugiyama, Shinji Kageyama, Toru Yakushigawa, Yoshihiro Matsumoto, Hatsumi Sugiyama, Yasuo Mori, Youichi Nojima, Kazuo Arihara, Hiromichi Ohmura, Yasushi Shimada, Nobuo Shio
Publikováno v:
Journal of the American College of Cardiology. 63:528-536
Objectives This study sought to assess whether spironolactone treatment reduces the high incidence of cardiovascular and cerebrovascular (CCV) morbidity and mortality in hemodialysis (HD) patients. Background Aldosterone receptor blockers reduce card
Autor:
Shinji Kageyama, Nobuo Shio, Toshikazu Sugiyama, Hiromichi Ohmura, Hatsumi Sugiyama, Toru Yakushigawa, Kazuo Arihara, Yoshihiro Matsumoto, Yasuo Mori
Publikováno v:
Cardiology. 114(1)
The Randomized Aldactone Evaluation Study showed that low-dose spironolactone treatment dramatically reduced mortality in patients with heart failure. However, the clinical use of this drug may be limited due to its tendency to cause life-threatening
Publikováno v:
Progress in Pediatric Cardiology. 1:91
Publikováno v:
Progress in Pediatric Cardiology. 1:98